BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28333250)

  • 1. The complexity of minocycline serum protein binding.
    Zhou J; Tran BT; Tam VH
    J Antimicrob Chemother; 2017 Jun; 72(6):1632-1634. PubMed ID: 28333250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of atypical nonlinear plasma−protein-binding behavior of tigecycline using an in vitro microdialysis technique.
    Mukker JK; Singh RP; Derendorf H
    J Pharm Sci; 2014 Mar; 103(3):1013-9. PubMed ID: 24549736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of serum protein binding on bacterial killing of minocycline.
    Xie LX; Zhou J; Ledesma KR; Merlau PR; Tam VH
    J Glob Antimicrob Resist; 2020 Jun; 21():252-254. PubMed ID: 31770603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minocycline and doxycycline concentrations in the serum, urine, prostatic fluid and prostatic tissue].
    Friesen A; Streifinger W; Hofstetter A; Rothenberger K; Adam D
    Fortschr Med; 1982 Apr; 100(13):605-8. PubMed ID: 6178665
    [No Abstract]   [Full Text] [Related]  

  • 5. Metal ion-tetracycline interactions in biological fluids. 2. Potentiometric study of magnesium complexes with tetracycline, oxytetracycline, doxycycline, and minocycline, and discussion of their possible influence on the bioavailability of these antibiotics in blood plasma.
    Berthon G; Brion M; Lambs L
    J Inorg Biochem; 1983 Aug; 19(1):1-18. PubMed ID: 6619838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
    Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
    Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metal ion-tetracycline interactions in biological fluids. Part 3. Formation of mixed-metal ternary complexes of tetracycline, oxytetracycline, doxycycline and minocycline with calcium and magnesium, and their involvement in the bioavailability of these antibiotics in blood plasma.
    Lambs L; Brion M; Berthon G
    Agents Actions; 1984 Jun; 14(5-6):743-50. PubMed ID: 6475671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of the tetracyclines with double-stranded RNAs of random base sequence: new perspectives on the target and mechanism of action.
    Chukwudi CU; Good L
    J Antibiot (Tokyo); 2016 Aug; 69(8):622-30. PubMed ID: 26786504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of serum lipid content on the binding of minocycline.
    Raff MJ; Summersgill JT; Fontana FJ; Barnwell PA; Waterman NG; Scharfenberger L
    J Antibiot (Tokyo); 1977 Jul; 30(7):593-6. PubMed ID: 408318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minocycline and doxycycline kinetics in chronic renal failure.
    Heaney D; Eknoyan G
    Clin Pharmacol Ther; 1978 Aug; 24(2):233-9. PubMed ID: 679601
    [No Abstract]   [Full Text] [Related]  

  • 11. Compartmental and noncompartmental pharmacokinetic analyses of minocycline hydrochloride in the dog.
    Wilson RC; Kitzman JV; Kemp DT; Goetsch DD
    Am J Vet Res; 1985 Jun; 46(6):1316-8. PubMed ID: 4026008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The penetration of minocycline into human sinus secretions.
    Worgan D; Daniel RJ
    Scott Med J; 1976 Oct; 21(4):197-9. PubMed ID: 996541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of minocycline in humans.
    Nelis HJ; De Leenheer AP
    Drug Metab Dispos; 1982; 10(2):142-6. PubMed ID: 6124399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tetracyclines: bacteriostatic or bactericidal drugs? In vitro studies with rolitetracycline, minocycline and doxycycline (author's transl)].
    Daschner F
    Zentralbl Bakteriol Orig A; 1977 Dec; 239(4):527-34. PubMed ID: 345688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Experimental Variables on the Protein Binding of Tigecycline in Human Plasma as Determined by Ultrafiltration.
    Dorn C; Kratzer A; Liebchen U; Schleibinger M; Murschhauser A; Schlossmann J; Kees F; Simon P; Kees MG
    J Pharm Sci; 2018 Feb; 107(2):739-744. PubMed ID: 28927988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline.
    Singh RSP; Mukker JK; Deitchman AN; Drescher SK; Derendorf H
    J Pharm Sci; 2016 Nov; 105(11):3409-3414. PubMed ID: 27616672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minocycline, doxycycline and tetracycline levels in serum and bronchial secretions of patients with chronic bronchitis.
    Ruhen RW; Tandon MK
    Pathology; 1975 Jul; 7(3):193-7. PubMed ID: 1196678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative activity of minocycline and doxycycline on mycoplasmas pathogenic for man].
    Bebear C; Cantet P; Renaudin H; Quentin C
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):577-80. PubMed ID: 3937130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of tigecycline in human plasma by LC-MS/MS and its application to population pharmacokinetics study in Chinese patients with hospital-acquired pneumonia.
    Shao R; Li X; Hu Y; Chen J; Lou H; Dai H
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28677837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent.
    Zhanel GG; Cheung D; Adam H; Zelenitsky S; Golden A; Schweizer F; Gorityala B; Lagacé-Wiens PR; Walkty A; Gin AS; Hoban DJ; Karlowsky JA
    Drugs; 2016 Apr; 76(5):567-88. PubMed ID: 26863149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.